Home » Newsletters » BioWorld Science

BioWorld Science

March 29, 2022

View Archived Issues

New monoglyceride lipase inhibitors identified at Roche

LG Chem discovers diacylglycerol O-acyltransferase 2 inhibitors

Seoul National University Hospital patents triglyceride-lowering peptides

Friedrich-Alexander-University Erlangen-Nuremberg presents mu-opioid receptor agonists

New USP7 inhibitors identified at Shouyao Holdings

Elicio Therapeutics' TLR9 agonist AMP-CpG induces potent immune and antitumoral effects

PF-07038124: a topical PDE4 inhibitor for atopic dermatitis and plaque psoriasis

LNP formulation development and production service launched by eTheRNA Manufacturing

Artelo collaborates with Trinity College Dublin to better understand FABP inhibition in cancer

Flavonoids as nuclear receptor 4A1 ligands for treating rhabdomyosarcoma

Novel NR4A1 antagonists show antitumor activity in syngeneic mouse model of colon cancer

Gain-of-function study identifies T-cell boosters

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...